122 related articles for article (PubMed ID: 20952760)
1. Tyrosine kinase-deficient EphB6 receptor-dependent alterations in proteomic profiles of invasive breast carcinoma cells as determined by difference gel electrophoresis.
Kandpal RP
Cancer Genomics Proteomics; 2010; 7(5):253-60. PubMed ID: 20952760
[TBL] [Abstract][Full Text] [Related]
2. Modulation of liver-intestine cadherin (Cadherin 17) expression, ERK phosphorylation and WNT signaling in EPHB6 receptor-expressing MDA-MB-231 cells.
Bhushan L; Tavitian N; Dey D; Tumur Z; Parsa C; Kandpal RP
Cancer Genomics Proteomics; 2014; 11(5):239-49. PubMed ID: 25331796
[TBL] [Abstract][Full Text] [Related]
3. EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.
Johnson C; Segovia B; Kandpal RP
Cancer Genomics Proteomics; 2016 09-10; 13(5):359-68. PubMed ID: 27566654
[TBL] [Abstract][Full Text] [Related]
4. A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.
Fox BP; Kandpal RP
Cancer Genomics Proteomics; 2011; 8(4):185-93. PubMed ID: 21737611
[TBL] [Abstract][Full Text] [Related]
5. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
[TBL] [Abstract][Full Text] [Related]
6. EphB6 receptor modulates micro RNA profile of breast carcinoma cells.
Bhushan L; Kandpal RP
PLoS One; 2011; 6(7):e22484. PubMed ID: 21811619
[TBL] [Abstract][Full Text] [Related]
7. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics.
Nagaraja GM; Othman M; Fox BP; Alsaber R; Pellegrino CM; Zeng Y; Khanna R; Tamburini P; Swaroop A; Kandpal RP
Oncogene; 2006 Apr; 25(16):2328-38. PubMed ID: 16314837
[TBL] [Abstract][Full Text] [Related]
8. The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.
Yu J; Bulk E; Ji P; Hascher A; Tang M; Metzger R; Marra A; Serve H; Berdel WE; Wiewroth R; Koschmieder S; Müller-Tidow C
Clin Cancer Res; 2010 Apr; 16(8):2275-83. PubMed ID: 20371680
[TBL] [Abstract][Full Text] [Related]
9. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application.
Fox BP; Kandpal RP
Biochem Biophys Res Commun; 2004 Jun; 318(4):882-92. PubMed ID: 15147954
[TBL] [Abstract][Full Text] [Related]
10. EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.
Fox BP; Kandpal RP
Oncogene; 2009 Apr; 28(14):1706-13. PubMed ID: 19234485
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional silencing of EphB6 receptor tyrosine kinase in invasive breast carcinoma cells and detection of methylated promoter by methylation specific PCR.
Fox BP; Kandpal RP
Biochem Biophys Res Commun; 2006 Feb; 340(1):268-76. PubMed ID: 16364251
[TBL] [Abstract][Full Text] [Related]
12. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
13. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
Tang XX; Zhao H; Robinson ME; Cohen B; Cnaan A; London W; Cohn SL; Cheung NK; Brodeur GM; Evans AE; Ikegaki N
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10936-41. PubMed ID: 10984508
[TBL] [Abstract][Full Text] [Related]
14. Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells.
Zadeh T; Lucero M; Kandpal RP
Cancer Genomics Proteomics; 2022; 19(1):19-26. PubMed ID: 34949656
[TBL] [Abstract][Full Text] [Related]
15. The kinase defective EPHB6 receptor tyrosine kinase activates MAP kinase signaling in lung adenocarcinoma.
Yu J; Bulk E; Ji P; Hascher A; Koschmieder S; Berdel WE; Müller-Tidow C
Int J Oncol; 2009 Jul; 35(1):175-9. PubMed ID: 19513565
[TBL] [Abstract][Full Text] [Related]
16. [FAK related non-kinase (FRNK) inhibits migration of a human breast carcinoma cell line MDA-MB-435].
Qin J; Liu ZX
Ai Zheng; 2006 Jul; 25(7):833-8. PubMed ID: 16831273
[TBL] [Abstract][Full Text] [Related]
17. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.
Narasimhan M; Ammanamanchi S
Cancer Res; 2008 Jul; 68(13):5185-92. PubMed ID: 18593918
[TBL] [Abstract][Full Text] [Related]
18. Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.
Peng L; Tu P; Wang X; Shi S; Zhou X; Wang J
J Mol Histol; 2014 Oct; 45(5):555-63. PubMed ID: 24912672
[TBL] [Abstract][Full Text] [Related]
19. DNA-based assay for EPHB6 expression in breast carcinoma cells as a potential diagnostic test for detecting tumor cells in circulation.
Fox BP; Kandpal RP
Cancer Genomics Proteomics; 2010; 7(1):9-16. PubMed ID: 20181626
[TBL] [Abstract][Full Text] [Related]
20. Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction.
Allonby O; El Zawily AM; Freywald T; Mousseau DD; Chlan J; Anderson D; Benmerah A; Sidhu V; Babu M; DeCoteau J; Freywald A
Cell Signal; 2014 Dec; 26(12):2645-57. PubMed ID: 25152371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
